Perbedaan Merck Tbk. dan Solusi Bangun Indonesia Tbk.: Merck Tbk. diperdagangkan di Rp3.900 (kapitalisasi pasar 1,76 T, volume 24 jam 63 rb), sedangkan Solusi Bangun Indonesia Tbk. diperdagangkan di Rp775 (kapitalisasi pasar 6,99 T). Perbedaan utamanya: Solusi Bangun Indonesia Tbk. jauh lebih besar — sekitar 4× kapitalisasi pasar Merck Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MERK | SMCB | |
|---|---|---|
Kapitalisasi Pasar | 1,76 T | 6,99 T |
Volume | 63 rb | — |
Lot | 630 | — |
Perputaran | 243,97 jt | — |
Harga Rata-rata | 3.872,46 | — |
Nilai Transaksi | 243,97 jt | — |
Harga Ekuilibrium Indikatif | 3.900 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.
Selengkapnya di halaman SMCB →